Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement

A review of international coverage and pricing strategies for personalized medicine and orphan drugs

(2017) Irina Degtiar   HEALTH POLICY

No Shortcuts on the Long Road to Evidence-Based Genomic Medicine

(2017) Muin J. Khoury   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Chest imaging in cystic fibrosis studies: What counts, and can be counted?

(2017) Rhonda Szczesniak et al.   Journal of Cystic Fibrosis

Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor

(2017) Meredith C. Fidler et al.   Journal of Cystic Fibrosis

What evidence do we need for biomarker qualification?

(2017) Chris Leptak et al.   Science Translational Medicine

Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study

(2017) Jose D Herazo-Maya et al.   Lancet Respiratory Medicine

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

(2017) Felix Ratjen et al.   Lancet Respiratory Medicine

Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities

(2016) Jennifer E. Ho et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

ARDS Subphenotypes Respond Differently to Randomized Fluid Management Strategy

(2016) Katie R Famous et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management

(2016) Francis X. McCormack et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium

(2016) Bruce E. Miller et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension

(2016) Anna R. Hemnes et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study

(2016) Tetsuro Araki et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Cystic Fibrosis and Its Management Through Established and Emerging Therapies

(2016) David R. Spielberg et al.   Annual Review of Genomics and Human Genetics

Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia

(2016) Tasha E. Fingerlin et al.   BMC GENETICS

Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung Cancer

(2016) Anil Vachani et al.   CHEST

Diagnostic Testing in Cystic Fibrosis

(2016) John Brewington et al.   CLINICS IN CHEST MEDICINE

Pulmonary Alveolar Proteinosis Syndrome

(2016) Takuji Suzuki et al.   CLINICS IN CHEST MEDICINE

Blood eosinophils as a marker of response to inhaled corticosteroids in COPD

(2016) Neil C. Barnes et al.   EUROPEAN RESPIRATORY JOURNAL

Proteomic study of acute respiratory distress syndrome: current knowledge and implications for drug development

(2016) Joseph E. Levitt et al.   Expert Review of Proteomics

Assessment of Clinical Criteria for Sepsis

(2016) Christopher W. Seymour et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

(2016) Mervyn Singer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries

(2016) Giacomo Bellani et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Biomarkers for cystic fibrosis drug development

(2016) Marianne S. Muhlebach et al.   Journal of Cystic Fibrosis

Genomics is failing on diversity

(2016) Alice B. Popejoy et al.   NATURE

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

(2016) Joshua D Campbell et al.   NATURE GENETICS

Genetic Misdiagnoses and the Potential for Health Disparities

(2016) Arjun K. Manrai et al.   NEW ENGLAND JOURNAL OF MEDICINE

Robust classification of bacterial and viral infections via integrated host gene expression diagnostics

(2016) Timothy E. Sweeney et al.   Science Translational Medicine

Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial

(2016) Henrik Watz et al.   Lancet Respiratory Medicine

BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis

(2016) Jonathan D W Evans et al.   Lancet Respiratory Medicine

Extensive Phenotyping of Individuals at Risk for Familial Interstitial Pneumonia Reveals Clues to the Pathogenesis of Interstitial Lung Disease

(2015) Jonathan A. Kropski et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation

(2015) Don D. Sin et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension

(2015) Raymond L. Benza et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Rare Variants inRTEL1Are Associated with Familial Interstitial Pneumonia

(2015) Joy D. Cogan et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Incidence and Prognostic Value of the Systemic Inflammatory Response Syndrome and Organ Dysfunctions in Ward Patients

(2015) Matthew M. Churpek et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Treatment-Related Biomarkers in Pulmonary Hypertension

(2015) Aparna C. Swaminathan et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy

(2015) Duncan H Whitney et al.   BMC Medical Genomics

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization

(2015) S Amur et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Genomic medicine and risk prediction across the disease spectrum

(2015) Maritha J. Kotze et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Number needed to treat: enigmatic results for exacerbations in COPD

(2015) Samy Suissa   EUROPEAN RESPIRATORY JOURNAL

Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects

(2015) Rajiv D. Machado et al.   HUMAN MUTATION

Building the foundation for genomics in precision medicine

(2015) Samuel J. Aronson et al.   NATURE

Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening

(2015) Bridget D Stuart et al.   NATURE GENETICS

A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer

(2015) Gerard A. Silvestri et al.   NEW ENGLAND JOURNAL OF MEDICINE

ClinGen — The Clinical Genome Resource

(2015) Heidi L. Rehm et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

(2015) Edward B. Garon et al.   NEW ENGLAND JOURNAL OF MEDICINE

A New Initiative on Precision Medicine

(2015) Francis S. Collins et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ventilation heterogeneity and the benefits and challenges of multiple breath washout testing in patients with cystic fibrosis

(2015) Alex Horsley et al.   Paediatric Respiratory Reviews

Correlation of serum vascular endothelial growth factor-D concentration with clinical presentation and course of lymphangioleiomyomatosis

(2015) Elżbieta Radzikowska et al.   RESPIRATORY MEDICINE

Newborn screening and the era of medical genomics

(2015) Ludmila Francescatto et al.   SEMINARS IN PERINATOLOGY

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD

(2015) Ian D Pavord et al.   THORAX

Potential Uses and Inherent Challenges of Using Genome-Scale Sequencing to Augment Current Newborn Screening

(2015) Jonathan S. Berg et al.   Cold Spring Harbor Perspectives in Medicine

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

(2015) Steven Pascoe et al.   Lancet Respiratory Medicine

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study

(2015) R Gisli Jenkins et al.   Lancet Respiratory Medicine

Implementing individualized medicine into the medical practice

(2014) Konstantinos N. Lazaridis et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS

Genetics and Early Detection in Idiopathic Pulmonary Fibrosis

(2014) Rachel K. Putman et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Relationship of DNA Methylation and Gene Expression in Idiopathic Pulmonary Fibrosis

(2014) Ivana V. Yang et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

C-X-C Motif Chemokine 13 (CXCL13) Is a Prognostic Biomarker of Idiopathic Pulmonary Fibrosis

(2014) Louis J. Vuga et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Eosinophilic inflammation in COPD: prevalence and clinical characteristics: Table 1–

(2014) Dave Singh et al.   EUROPEAN RESPIRATORY JOURNAL

Periostin is required for maximal airways inflammation and hyperresponsiveness in mice

(2014) J. Kelley Bentley et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Comprehensive molecular profiling of lung adenocarcinoma

(2014) Eric A. Collisson et al.   NATURE

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

(2014) Talmadge E. King et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

(2014) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine

(2014) Jason L Vassy et al.   Trials

Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation

(2014) Bridget D Stuart et al.   Lancet Respiratory Medicine

Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials

(2014) Carolyn S Calfee et al.   Lancet Respiratory Medicine

An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

(2013) William D. Travis et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Toll-like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis

(2013) David N. O’Dwyer et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis

(2013) Brett Ley et al.   ANNALS OF INTERNAL MEDICINE

Change in Sweat Chloride as a Clinical End Point in Cystic Fibrosis Clinical Trials

(2013) Anthony G. Durmowicz et al.   CHEST

Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis

(2013) Hillary Loomis-King et al.   CURRENT OPINION IN PHARMACOLOGY

Physicians' Preparedness for Integration of Genomic and Pharmacogenetic Testing into Practice Within a Major Healthcare System

(2013) Christina G. Selkirk et al.   Genetic Testing and Molecular Biomarkers

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

(2013) R. P. Dellinger et al.   INTENSIVE CARE MEDICINE

Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis

(2013) Anna L. Peljto et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The State of US Health, 1990-2010

(2013) Christopher J. L. Murray   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sweat chloride as a biomarker of CFTR activity: Proof of concept and ivacaftor clinical trial data

(2013) Frank J. Accurso et al.   Journal of Cystic Fibrosis

Lung clearance index: Evidence for use in clinical trials in cystic fibrosis

(2013) L. Kent et al.   Journal of Cystic Fibrosis

Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis

(2013) Kanji Uchida et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Updated Clinical Classification of Pulmonary Hypertension

(2013) Gerald Simonneau et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis

(2013) Tasha E Fingerlin et al.   NATURE GENETICS

MUC5B Promoter Polymorphism and Interstitial Lung Abnormalities

(2013) Gary M. Hunninghake et al.   NEW ENGLAND JOURNAL OF MEDICINE

ClinVar: public archive of relationships among sequence variation and human phenotype

(2013) Melissa J. Landrum et al.   NUCLEIC ACIDS RESEARCH

Genetic testing insurance coverage trends: a review of publicly available policies from the largest US payers

(2013) Michael D Graf et al.   Personalized Medicine

The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population

(2013) Raphael Borie et al.   PLoS One

Who Gets Genomic Testing for Breast Cancer Recurrence Risk?

(2013) J.T. DeFrank et al.   Public Health Genomics

Galectin-3: its role in asthma and potential as an anti-inflammatory target

(2013) Peng Gao et al.   RESPIRATORY RESEARCH

Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis

(2013) J. D. Herazo-Maya et al.   Science Translational Medicine

Genomic Medicine: A Decade of Successes, Challenges, and Opportunities

(2013) J. J. McCarthy et al.   Science Translational Medicine

Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis

(2013) Ivana V Yang et al.   THORAX

European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions: Table 1

(2013) C Michael Roberts et al.   THORAX

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis

(2013) Carmel J Stock et al.   THORAX

Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D- CFTR mutation and preserved spirometry: a randomised controlled trial

(2013) Jane Davies et al.   Lancet Respiratory Medicine

Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study

(2013) Imre Noth et al.   Lancet Respiratory Medicine

Altered DNA Methylation Profile in Idiopathic Pulmonary Fibrosis

(2012) Yan Y. Sanders et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Patients with Idiopathic Pulmonary Fibrosis with Antibodies to Heat Shock Protein 70 Have Poor Prognoses

(2012) Rehan A. Kahloon et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material

(2012) Niall D. Ferguson et al.   INTENSIVE CARE MEDICINE

Periostin promotes chronic allergic inflammation in response to Th2 cytokines

(2012) Miho Masuoka et al.   JOURNAL OF CLINICAL INVESTIGATION

Pulmonary fibrosis: patterns and perpetrators

(2012) Paul W. Noble et al.   JOURNAL OF CLINICAL INVESTIGATION

The acute respiratory distress syndrome

(2012) Michael A. Matthay et al.   JOURNAL OF CLINICAL INVESTIGATION

The Influence of Health Care Policies and Health Care System Distrust on Willingness to Undergo Genetic Testing

(2012) Katrina Armstrong et al.   MEDICAL CARE

Clinical and economic challenges facing pharmacogenomics

(2012) J Cohen et al.   PHARMACOGENOMICS JOURNAL

Global Methylation Patterns in Idiopathic Pulmonary Fibrosis

(2012) Einat I. Rabinovich et al.   PLoS One

Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis

(2012) Seung-Ick Cha et al.   RESPIRATORY RESEARCH

Number needed to treat in COPD: exacerbations versus pneumonias

(2012) Samy Suissa   THORAX

Peripheral blood biomarkers in idiopathic pulmonary fibrosis

(2012) Rekha Vij et al.   Translational Research

Barriers to the Use of Personalized Medicine in Breast Cancer

(2012) Christine B. Weldon et al.   Journal of Oncology Practice

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

(2011) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis

(2011) Thomas J. Richards et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Procalcitonin Algorithms for Antibiotic Therapy Decisions

(2011) Philipp Schuetz   ARCHIVES OF INTERNAL MEDICINE

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Knowledge About Genomic Recurrence Risk Testing Among Breast Cancer Survivors

(2011) Isaac M. Lipkus et al.   JOURNAL OF CANCER EDUCATION

Periostin Regulates Goblet Cell Metaplasia in a Model of Allergic Airway Inflammation

(2011) S. Sehra et al.   JOURNAL OF IMMUNOLOGY

Genomic sequencing in clinical trials

(2011) Karen K Mestan et al.   Journal of Translational Medicine

Genomics for the world

(2011) Carlos D. Bustamante et al.   NATURE

A Variant in the Promoter ofMUC5Band Idiopathic Pulmonary Fibrosis

(2011) Yingze Zhang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis

(2011) Francis X. McCormack et al.   NEW ENGLAND JOURNAL OF MEDICINE

A CommonMUC5BPromoter Polymorphism and Pulmonary Fibrosis

(2011) Max A. Seibold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Provision of personalized genomic diagnostic technologies for breast and colorectal cancer: an analysis of patient needs, expectations and priorities

(2011) Amalia M Issa et al.   Personalized Medicine

Survey of US public attitudes toward pharmacogenetic testing

(2011) S B Haga et al.   PHARMACOGENOMICS JOURNAL

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

(2011) R. D. Schreiber et al.   SCIENCE

MicroRNAs in idiopathic pulmonary fibrosis

(2011) Kusum V. Pandit et al.   Translational Research

Vasoreactivity to Inhaled Nitric Oxide with Oxygen Predicts Long-Term Survival in Pulmonary Arterial Hypertension

(2011) Rajeev Malhotra et al.   Pulmonary Circulation

Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis

(2010) Harold R. Collard et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Surfactant Protein C Mutations Are the Basis of a Significant Portion of Adult Familial Pulmonary Fibrosis in a Dutch Cohort

(2010) Coline H. M. van Moorsel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Patient-derived Granulocyte/Macrophage Colony–Stimulating Factor Autoantibodies Reproduce Pulmonary Alveolar Proteinosis in Nonhuman Primates

(2010) Takuro Sakagami et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis

(2010) Brett Ley et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Women's experiences with genomic testing for breast cancer recurrence risk

(2010) Janice P. Tzeng et al.   CANCER

The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis

(2010) R. Amin et al.   EUROPEAN RESPIRATORY JOURNAL

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis

(2010) Gang Liu et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome

(2010) Laurent Papazian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis

(2010) Kazuki Furuhashi et al.   RESPIRATORY MEDICINE

Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis

(2010) Nicoline M. Korthagen et al.   RESPIRATORY MEDICINE

Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function

(2010) R. Amin et al.   THORAX

Coverage Policy Development for Personalized Medicine: Private Payer Perspectives on Developing Policy for the 21-Gene Assay

(2010) Julia R. Trosman et al.   Journal of Oncology Practice

Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis

(2009) Antje Prasse et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Postal survey of physicians and laboratories: Practices and perceptions of molecular oncology testing

(2009) Fiona A Miller et al.   BMC HEALTH SERVICES RESEARCH

Prognostic and Pathogenetic Value of Combining Clinical and Biochemical Indices in Patients With Acute Lung Injury

(2009) Lorraine B. Ware et al.   CHEST

Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock*

(2009) Mark E. Mikkelsen et al.   CRITICAL CARE MEDICINE

Personalized medicine: Factors influencing reimbursement

(2009) Lisa M. Meckley et al.   HEALTH POLICY

Cellular and Molecular Basis of Pulmonary Arterial Hypertension

(2009) Nicholas W. Morrell et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Human GM-CSF Autoantibodies and Reproduction of Pulmonary Alveolar Proteinosis

(2009) Takuro Sakagami et al.   NEW ENGLAND JOURNAL OF MEDICINE

Assessing Patient Readiness for the Clinical Adoption of Personalized Medicine

(2009) A.M. Issa et al.   Public Health Genomics

Factors Influencing Uptake of Pharmacogenetic Testing in a Diverse Patient Population

(2009) J. O’Daniel et al.   Public Health Genomics

Next generation disparities in human genomics: concerns and remedies

(2009) Anna C. Need et al.   TRENDS IN GENETICS

Genetic Defects in Surfactant Protein A2 Are Associated with Pulmonary Fibrosis and Lung Cancer

(2008) Yongyu Wang et al.   AMERICAN JOURNAL OF HUMAN GENETICS

PD-1 and Its Ligands in Tolerance and Immunity

(2008) Mary E. Keir et al.   Annual Review of Immunology

Diagnostic Potential of Serum VEGF-D for Lymphangioleiomyomatosis

(2008) Lisa R. Young et al.   NEW ENGLAND JOURNAL OF MEDICINE

MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis

(2008) Ivan O Rosas et al.   PLOS MEDICINE

Is Metalloproteinase-7 Specific for Idiopathic Pulmonary Fibrosis?

(2007) Jin Won Huh et al.   CHEST